Global Strategic Business Outlook on the Genetic Testing

Dublin, July 09, 2018 (GLOBE NEWSWIRE) -- The "Genetic Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is further analyzed by the following Segments:

• Prenatal & Newborn Genetic Testing
• Pharmacogenomic Testing
• Predictive Diagnostics

The report profiles 88 companies including many key and niche players such as:

• 23andMe, Inc. (USA)
• Abbott Laboratories (USA)
• AutoGenomics, Inc. (USA)
• Biocartis NV (Belgium)
• BioRad Laboratories (USA)
• Cepheid Inc. (USA)
• ELITech Group S.P.A. (France)
• Illumina, Inc. (USA)
• Laboratory Corporation of America Holdings (USA)
• Sequenom, Inc. (USA)
• Luminex Corporation (USA)
• Natera, Inc. (USA)
• PerkinElmer, Inc. (USA)
• QIAGEN N.V. (The Netherlands)
• Quest Diagnostics, Inc. (USA)
• Roche Diagnostics Corp. (Switzerland)
• Roche Molecular Diagnostics, Inc. (USA)
• Thermo Fisher Scientific (USA)
• Transgenomic, Inc. (USA)

Key Topics Covered 1. GLOBAL MARKET OVERVIEW A Curtain Raiser Top Ten Genetic Disorders Worldwide Genetic Testing: Heralding a New Era Genetic Testing Paves the Way for Personalized Medicine Genetic Testing A Critical Part of the Rapidly Developing In-Vitro Diagnostics (IVD) Market Genetic Testing: The Rapidly Growing Segment of Molecular Diagnostics Market An Overview of Current Technologies in Genetic Testing Biomarker Discovery Leads to Advanced Genetic Testing List of US-FDA Approved Biomarkers for Cancer Ballooning Global Population Offers Increased Growth Opportunities Aging Population Drives the Genetic Testing Market Improving Healthcare Expenditure to Drive Demand Competitive Overview 2. SEGMENTAL REVIEW Prenatal Testing Market to Rise List of Genetic Disorders by Event, Genetic Manifestation and Prevalence Prenatal Testing Changing the World of Pregnancy Care Prenatal Testing A Rudimentary Overview Conventional Invasive Pre-Natal Diagnostic Techniques A Risky Affair Technological Advancements Boost Prenatal Genetic Screening Market Predictive Diagnostics Breast Cancer Gene Testing Market to Expand Strongly Myriad Genetics The Unquestioned Leader in Breast Cancer Testing Routine Clinical Testing Vs. Predictive Genetic Testing Increasing Incidence and Prevalence of CDDs: A Major Growth Driver Discovery of Novel Biomarkers Crucial to Predictive Diagnostics Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease Dearth of Genetic Counselors A Major Hurdle for the Predictive Genetic Testing Pharmacogenomics Development Augurs Growth of Genetic Testing Market 3. MARKET TRENDS Direct-to-Consumer Genetic Testing A Key Trend in the Genetic Testing Market Direct-to-Consumer Genetic Testing is Here to Stay Creating a Platform for New Companies Business Models for DTC Genetic Testing Firms Growing Prominence of DTC Genetic Testing: A Boon or a Curse? Genetic Screening of Newborns to Rise Pre-implantation Genetic Diagnosis (PGD) A Major Driver for the Genetic Testing Market Whole Genome Sequencing Boon or Bane to Genetic Testing? Utility of Genetic Testing for Warfarin Study As Technologies Grow, Need for Better Interpretation of Tests Increases Selling Collected Patient Genetic Information Becomes a New Business Oncology A Key Focus Area for Genetic Testing Liquid Biopsy to Change the Face of Cancer Diagnosis and Treatment Genetic Testing May Aid CNS Disease Therapeutics Neurodegenerative Diseases Major Focus Area for Genetic Testing Alzheimer's Disease Huntington's Disease Genetic Testing An Indispensable Tool for Cystic Fibrosis Histocompatibility Testing Next-Generation Sequencing A Giant Leap in Genome Sequencing Pediatric Genetic Testing for Screening Adult Onset Disorders Fast Gaining Acceptance Better Regulatory Safeguards Required for Global Genetic Testing Industry Challenges Faced Controversial Applications Marr Genetic Testing Market Genetic Counseling: Gaining Momentum Online Approach Gains Momentum Recommendations of ACOG and ACGM Augments Demand for Cystic Fibrosis Testing Ethical Issues & Need for Appropriate Regulating Policies Issues Related to Genetic Tests for Obesity Diagnosis and Treatment during Pregnancy An Effective Way of Alleviating Syphilis Related Deaths and Stillbirths 4. MOLECULAR DIAGNOSTICS MARKET - AN INSIGHT Global Molecular Diagnostics on a High Growth Curve Automation Driving Global Market Molecular Diagnostics: Marking the Convergence of Numerous Technologies MDx Market for Infectious Diseases Zooming Ahead Aging Population, Disease Incidence Fundamental Drivers of Growth Pharmaceutical Firms Carving Their Niche in Molecular Diagnostics Market Towards Tailoring the Right Treatment for the Right Disease Limited Reimbursements by Third Party Payers A Stumbling Block Disease-Specific Molecular Diagnostics to Deliver Improved Clinical Outcomes Molecular Diagnostics and Intellectual Property Business Opportunities in the Offing Medical Training and Practice Challenges Hurdles All the Way for Companies Eyeing Molecular Diagnostics Product Marketing Key to Commercial Success Integration of Molecular Diagnostics into Therapeutics Molecular Diagnostics Moving from Centralization to Decentralization Competitive Landscape of the Molecular Diagnostics Market New Entrants Eye Unmet Needs 5. PRODUCT OVERVIEW 6. PRODUCT LAUNCHES/INNOVATIONS AutoGenomics Rolls Out INFINITI H. pylori Assay 23andMe Obtains FDA Approval for Personal Genetic Test for Select Diseases Invitae Adds News Tests to Proactive Genetic Testing Repertoire Thermo Fisher Scientific Launches CarrierScan Assay MedGenome Unveils Claria Carrier Screening Test in India Phosphorus Rolls Out Advances Tests for Inherited Conditions Cancer Genetics Launches Genomic Panel for HBOC Illumina, Bio-Rad Launch Single-Cell Genomic Sequencing Solution MyHeritage Introduces MyHeritage DNA Service Thermo Fisher Scientific Unveils Clariom Pico Assays IBM Watson Health, Quest Diagnostics Roll Out IBM Watson Genomics Thermo Fisher Scientific Introduces PharmacoScan Solution Good Start Genetics Launches EmbryVu PGS Test Spark Therapeutics Introduces Testing for Inherited Retinal Diseases AutoGenomics Launches INFINITI Buccal Sample Collection Kit FutuTest Launches FERTIFY Genetic Test Quest Diagnostics Introduces New Cancer Test Services Good Start Genetics Launches Next-Generation Embryo Screening Solution Invitae Introduces Pediatric Tests for Rare Disease and Pediatric Genetics Contextual Genomics Introduces Cancer Genome Test Transgenomic Introduces CMT NGS Panel Ambry Genetics Rolls Out Suite of Genetic Testing Panels for Epilepsy Good Start Genetics Introduces EmbryVu PGS Test 23andMe Secures FDA Approval for New Trimmed Down DNA-based Health Analysis Roche Rolls Out Oncology Assay AutoGenomics Launches INFINITI SMART Transgenomic Rolls Out Transgenomic Leukodystrophy NGS Panel Color Genomics Rolls Out New Test for Cancer-Associated Genes PerkinElmer Launches Genetic Screening Processor Instruments in China Mayo Clinic Launches Eight NGS Panels for Cardiac Disorders Sequenom Laboratories and Recombine Launch HerediT UNIVERSAL Multipicom NV Launches ADH MASTR v2 assay 23andMe Launches Drug Development Unit Quest Diagnostics Launches Neurome Exome Sequencing Service Roche Launches cobas 6800/8800 Systems Agena Biosciences Launches MassARRAY 24-Well System FDA Grants Marketing Approval to 23andMe's DTC Bloom Syndrome Carrier Genetic Test Transgenomic to Launch ICE COLD-PCR Technology Rosetta Launches Sequencing-based Oncology Tests by Admera Health MedGenome Labs Launches Panorama Prenatal Test Ambry Genetics Launches CVD Genetic Testing Panels Exceltox Launches Pharmacogenomic Testing PerkinElmer Launches SCID Screening Test in North America Quest Diagnostics Introduces BRCAvantage Plus Genetic Technologies Launches BREVAGenplus Test Sophia Genetics Receives CE-IVD Certification for Genetic Testing Response Genetics Launches Immuno-Oncology Assay DeNA Life Science Launches Mycode Genetic Testing Service Pathway Genomics Launches BRCATrue Test Courtagen Launches Genetic Sequencing Tests for Neurodevelopmental Disorders Myriad Genetics Launches EndoPredict Breast Cancer Test Assurex Health Expands GeneSight Pharmacogenomic Testing Platform Illumina to Launch VeriSeq Embryo Screening Tool GENEWIZ Launches PGxOne Pharmacogenomic Test Ambry Genetics Launches ExomeNext and ExomeNext-Rapid Genetic Tests Pathway Genomics Launches Genetic Test to Detect Risk of Colorectal Cancer Mount Sinai Laboratory Develops Accurate Genetic Test for SMA 7. RECENT INDUSTRY ACTIVITY Agilent Inks Deal to Take Over Multiplicom DNA Diagnostics Center Acquires IDENTIGENE Genetic Analysis and Bio-Rad Ink Deal for Transferring Commercialization Rights to GA-map Thermo Fisher Files for PMA Approval of its Oncomine Universal Dx Test LabCorp Takes Over Sequenom WuXi AppTec and AutoGenomics Team Up to Launch Advanced Molecular Diagnostic Technology In China Danaher to Take Over Cepheid Quest Diagnostics to Offer Genetic Testing Services for Ancestry Transgenomic and LabCorp Sign Commercial License Agreement for TBIO's DNA Susceptibility Testing IP Next Biosciences Merges with Genesis Genetics PerkinElmer Expands Services in India PerkinElmer Takes Over Vanadis Diagnostics AutoGenomics and McKesson to Jointly Distribute INFINITI Molecular Diagnostic Systems and Related Products Transgenomic Divests GAP Business Thermo Fisher Teams Up with Novartis and Pfizer for Developing NGS Oncology Test NeoGenomics Acquires Clarient MedGenome to Build Data Specific to India for Testing Kits Roche to Take Over Kapa Biosystems Natera Selects DNAnexus Cloud Genomics Platform for its Genetic Tests ESPERITE Acquires InKaryo Transgenomic Signs Agreement with Exiqon A/S Quest Diagnostics and Myriad Genetics End BRCA Gene Patent Litigation Roche to Acquire Majority Share of Foundation Medicine Roche Acquires Ariosa Diagnostics GSK Collaborates with GE on Oncology Genetic Testing Cancer Genetics to Acquire Gentris Corporation Natera Partners with Mount Sinai Genetic Testing Laboratory Transgenomic to Sell SURVEYOR Nuclease Technology to Integrated DNA Technologies Transgenomic Collaborates with Raptor Pharmaceuticals for Genetic Testing Services AutoGenomic Signs Agreement with Genomas Cancer Genetics Acquires BioServe Biotechnologies PerkinElmer to Close Its Signature Genomics Testing Business LifeLabs Medical Laboratory Services Buys out Centogene's Canadian Business CytoScan Dx Assay by Affymetrix Receives FDA Approval 8. FOCUS ON SELECT PLAYERS 23andMe, Inc. (USA) Abbott Laboratories (USA) AutoGenomics, Inc. (USA) Biocartis NV (Belgium) BioRad Laboratories (USA) Cepheid Inc. (USA) ELITech Group S.P.A. (France) Illumina, Inc. (USA) Laboratory Corporation of America Holdings (USA) Sequenom, Inc. (USA) Luminex Corporation (USA) Natera, Inc. (USA) PerkinElmer, Inc. (USA) QIAGEN N.V. (The Netherlands) Quest Diagnostics, Inc. (USA) Roche Diagnostics Corp. (Switzerland) Roche Molecular Diagnostics, Inc. (USA) Thermo Fisher Scientific (USA) Transgenomic, Inc. (USA) 9. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 88 (including Divisions/Subsidiaries 97)

• The United States (60)
• Canada (5)
• Japan (1)
• Europe (23)
  • France (2)
  • Germany (3)
  • The United Kingdom (2)
  • Spain (1)
  • Rest of Europe (15)
• Asia-Pacific (Excluding Japan) (5)
• Middle East (2)
• Africa (1)

For more information about this report visit https://www.researchandmarkets.com/research/f...tegic?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Genomics, Diagnostics